Posted on by Mike Yeomans
Pitt innovators were issued 6 U.S. patents in March 2022. Featured patent: 11,272,840 “Touch Probe Passively Powered Wireless Stent Antenna for Implanted Sensor Powering Interrogation” Smart stents are capable of …
Posted on by Mike Yeomans
The National Academy of Inventors (NAI) has selected three University of Pittsburgh professors among 83 academic inventors for the 2022 class of NAI Senior Members. They are: Antonio D’Amore, Research …
Posted on by Mike Yeomans
Mark Adkins, Chief Executive Officer of Lean Med – a Pittsburgh-based startup – will share his inspirational startup journey. You’ll learn how an idea from a Pitt medical student turned …
Posted on by Mike Yeomans
The University of Pittsburgh made a significant move up the list of the top recipients of U.S. utility patents among worldwide universities in 2020, according to the National Academy of …
Posted on by Mike Yeomans
Dan Broderick, an experienced healthcare and biotech investor and entrepreneur, is joining the University of Pittsburgh Innovation Institute as Entrepreneur in Residence effective June 1, 2021. Most recently Broderick …
Posted on by Mike Yeomans
If ever there was a time to celebrate the power of innovation, it is in the wake of the wave of innovation unleashed by the SARS CoV-2 pandemic. At the …
Posted on by Mike Yeomans
Pancreatic cancer. Just hearing those words produces a chilling feeling of dread. It is among the most deadly and difficult to treat cancers, in part because it forms dense tumors …
Posted on by Mike Yeomans
The Henry L. Hillman Foundation has committed $25 million to the University of Pittsburgh to support research into vision restoration and care, in addition to supporting the region’s burgeoning life …
Posted on by Mike Yeomans
University of Pittsburgh Faculty Elected Senior Members of the National Academy of Inventors The National Academy of Inventors (NAI) has selected three University of Pittsburgh professors among 61 academic inventors …
Posted on by Mike Yeomans
Stephen Popielarski, PhD, had been a mentor for Phase I Ventures, a Philadelphia-based startup accelerator that matches university startups with experienced entrepreneurs when he was asked to review a batch …
Posted on by Mike Yeomans
BlueSphere licensed technology from the lab of Mark Shlomchik, chair of the Department of Immunology at the Pitt Medical School, aimed at developing personalized T-cell therapies for cancer and other …
Posted on by Mike Yeomans
Forge Biologics, a Columbus, Ohio-based gene therapy manufacturing and development company, is set to begin Phase I and 2 clinical trials of a gene therapy to treat Krabbe Disease, a …